ChemicalBook > Product Catalog >Biochemical Engineering >Biochemical Reagents >Agonist Inhibitors >AZD-5069

AZD-5069

AZD-5069 Suppliers list
Company Name: Chembest Research Laboratories Limited  
Tel: 021-20908456
Email: sales@BioChemBest.com
Company Name: ShangHai Caerulum Pharma Discovery Co., Ltd.  
Tel: 18149758185 18149758185
Email: sales-cpd@caerulumpharma.com
Company Name: Bide Pharmatech Ltd.  
Tel: 400-164-7117 18317119277
Email: product02@bidepharm.com
Company Name: AdooQ Bioscience CHINA  
Tel: 025-58849295
Email: info@adooq.cn
Company Name: Shanghai XingMo Biotechnology Co., Ltd.  
Tel: +86 13524779951; 13524779951
Email: 2075692521@qq.com

AZD-5069 manufacturers

  • AZD-5069
  • AZD-5069 pictures
  • $31.00
  • 2026-07-27
  • CAS:878385-84-3
  • Purity: 99.92%
  • Supply Ability: 10g
AZD-5069 Basic information
Product Name:AZD-5069
Synonyms:AZD-5069;ACT-281959;CPDD1543;AZD 5069; AZD5069;CS-2808;AZD-5069; AZD 5069; AZD5069;878385-84-3;N-(2-((2,3-difluorobenzyl)thio)-6-(((2R,3S)-3,4-dihydroxybutan-2-yl)oxy)pyrimidin-4-yl)azetidine-1-sulfonamide;1-Azetidinesulfonamide, N-[2-[[(2,3-difluorophenyl)methyl]thio]-6-[(1R,2S)-2,3-dihydroxy-1-methylpropoxy]-4-pyrimidinyl]-
CAS:878385-84-3
MF:C18H22F2N4O5S2
MW:476.52
EINECS:
Product Categories:APIs
Mol File:878385-84-3.mol
AZD-5069 Structure
AZD-5069 Chemical Properties
Melting point 149-152°C
Boiling point 680.5±65.0 °C(Predicted)
density 1.56±0.1 g/cm3(Predicted)
storage temp. Hygroscopic, -20°C Freezer, Under inert atmosphere
solubility DMSO (Slightly), Methanol (Slightly)
pka4.56±0.20(Predicted)
form Solid
color White to Off-White
Safety Information
HS Code 2935909099
MSDS Information
AZD-5069 Usage And Synthesis
DescriptionAZD5069 is a potent, selective reversible (time and temperature dependent) antagonist of the human CXCR2 receptor that used for caner treatment.
UsesAZD-5069 is a potent and selective CXCR2 antagonist with potential as a therapeutic agent in inflammatory conditions.
Biological ActivityAZD 5069 is an antagonist of chemokine receptor 2 (CXCR2; IC50 = 0.79 nM in a radioligand binding assay). It inhibits CXCL1-induced CD11b expression in and chemotaxis of isolated human neutrophils (pA2s = 6.9 and 9.1, respectively). AZD 5069 (3 and 10 μmol/kg) inhibits bronchoalveolar lavage fluid (BALF) neutrophil influx in a rat model of LPS-induced lung neutrophilia and non-allergic airway inflammation.
IC 50125I-IL-8-CXCR2
AZD-5069 Preparation Products And Raw materials
Tag:AZD-5069(878385-84-3) Related Product Information
N-(6-(((2R,3S)-3,4-dihydroxybutan-2-yl)oxy)-2-((4-fluorobenzyl)thio)pyrimidin-4-yl)-3-methylazetidine-1-sulfonamide AZD-5069 AZD 9668 1-Pentanol, 2-[[2-aMino-5-[[(1S)-1-phenylethyl]thio]thiazolo[4,5-d]pyriMidin-7-yl]aMino]-4-Methyl-, (2R)- AZD2098 7-Methyl-5-[(3-piperazin-1-ylMethyl)-1,2,4-oxadiazol-5-yl-]-2-[4-(trifluoroMethoxy)benzyl]-2,3-dihydro-1H-isoindol-1-one Methanesulphonate